A pharmaceutical company, or drug company, is a commercial business licensed to research, develop, market and/or distribute drugs, most commonly in the context of healthcare.
For more information about the three components, click here.
India’s drug regulator authorized the country’s first nasal spray vaccine on Tuesday, marking a big step toward increasing the availability of newly popular needle-free vaccines around the world.
Due to drug overdoses and COVID-19 deaths, life expectancy in the U.S. has dropped for the second straight year.
California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
Editas Medicine has confirmed that a cell therapy for sickle cell disease has successfully engrafted into the first patient dosed in a phase 1/2 trial, which means—for those of us without a science degree—the therapy has been accepted by the patient’s body and is starting to create new blood cells as planned.
New medical innovations provides glimmer of hope for the development of complex kidney organoids that can be used as a substitute for kidney transplants.
The Coalition for Epidemic Preparedness Innovations will provide funding up to $375,000 to support the development of laboratory tools to assess monkeypox vaccines.
Use of computational software in drug research is growing, and some big tech companies are angling for a piece of this market. Cadence Design Systems is entering the life sciences sector through the $500 million acquisition of OpenEye Scientific, a company that provides computational drug design software to the pharmaceutical industry.
Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.
The bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line.
Pfizer’s Xalkori has gained its fourth FDA approval in 11 years to treat an ALK-positive cancer.
Scientists have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma.
The first US application for sale of a non-prescription birth control pill has taken on new meaning after the Supreme Court decision ending the constitutional right to abortion.
